Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 486-492

  Garcia Rios, A ^a,b   Perez Martinez, P ^a   Fuentes, F ^a   Mata, P ^c   Lopez Miranda, J ^a   Alonso, R ^c   Rodriguez, F ^d   Garcia Olid, A ^a   Ruano, J ^a   Ordovas, J M ^b   Perez Jimenez, F ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b TUFTS UNIVERSITY   (United States)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

ABCG5 G8 polymorphisms; Familial hypercholesterolemia; Interaction; Lipids; Smoking

Indexed keywords

ASPARTIC ACID; CHOLESTEROL; CYSTEINE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTIDINE; LIPID; MEMBRANE PROTEIN; PROTEIN ABCG5; PROTEIN ABCG8; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 77953228947     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.010     Document Type: Article

References (36)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic and molecular bases of inherited disease 2001, 2863-2913. McGraw-Hill, New York, NY. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Ferrières J., Lambert J., Lussier-Cacan S., Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 1995, 92(3):290-295.
3. Lu K., Lee M.H., Yu H., et al. Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes ABCG5 and ABCG8. J Lipid Res 2002, 43:564-578.
4. Oram J.F., Vaughan A.M. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res 2006, 99(10):1031-1043.
5. Yu L., York J., von Bergmann K., et al. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003, 278(18):15565-15570.
6. Calpe-Berdiel L., Rotllan N., Fiévet C., et al. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res 2008, 49(9):1904-1911.
7. Naik S.U., Wang X., Da Silva J.S., et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006, 113(1):90-97.
8. Kajinami K., Brousseau M.E., Ordovas J.M., Schaefer E.J. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis 2004, 175(2):287-293.
9. Kajinami K., Brousseau M.E., Nartsupha C., Ordovas J.M., Schaefer E.J. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res 2004, 45(4):653-656.
10. Santosa S., Demonty I., Lichtenstein A.H., Ordovas J.M., Jones P.J.H. Single nucleotide polymorphisms in ABCG5 and ABCG8 are associated with changes in cholesterol metabolism during weight loss. J Lipid Res 2007, 48:2607-2613.
11. Miwa K., Inazu A., Kobayashi J., et al. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. Clin Sci (Lond) 2005, 109(2):183-188.
12. Koeijvoets K.C., van der Net J.B., Dallinga-Thie G.M., et al. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia. Atherosclerosis 2009, 204(2):453-458.
13. Pérez-Martínez P., Gómez P., Paz E., et al. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet. Nutr Metab Cardiovasc Dis. 2001, 11(4):237-243.
14. Junyent M., Tucker K.L., Smith C.E., et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican health study. J Lipid Res 2009, 50(3):565-573.
15. Alonso R., Mata N., Badimon L., Perez-Jimenez F., Mata P. Prognostic factors of cardiovascular disease mortality and morbidity in a cohort of families with genetic diagnoses of familial hypercholesterolemia. Nat Rev Cardiol 2009, 6(4):23-27.
16. Allain C.C., Poon L.S., Chang C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
17. Bucolo G., David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973, 19:476-482.
18. Wilson P.W., Zech L.A., Gregg R.E., et al. Estimation of VLDL cholesterol in hyperlipidemia. Clin Chem Acta 1985, 151(3):285-291.
19. 2. Clin Chem 1983, 29:2026-2030.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of a preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
21. Riepponem P., Marniemi J., Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987, 47:739-744.
22. Tejedor D., Castillo S., Mozas P., et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005, 51(7):1137-1144.
23. Marinescu V.D., Kohane I.S., Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005, 6:79.
24. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999, 14:143-149.
25. R Development Core Team R: a language and environment for statistical computing 2007, R Foundation for Statistical Computing, Vienna.
26. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70:425-434.
27. Jansen A.C., van Aalst-Cohen E.S., Tanck M.W., et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 2004, 256(6):482-490.
28. van der Net J.B., Oosterveer D.M., Versmissen J., et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur Heart J 2008, 29(18):2195-2201.
29. Alonso R., Mata N., Castillo S., et al. Cardiovascular disease in familial hipercolesterolemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 2008, 200(2):315-321.
30. Repa J.J., Berge K.E., Pomajzl C., et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002, 277:18793-18800.
31. Junyent M, Tucker KL, Smith CE, et al. The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health Study. Nutr Metab Cardiovasc Dis. 2009 [Epub ahead of print].
32. Schultz J.R., Tu H., Luk A., et al. Role of LXRs in control of lipogenesis. Genes Dev 2000, 14:2831-2838.
33. Horton D.J., Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999, 10:143-150.
34. Repa J.J., Liang G., Ou J., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SRE-BP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000, 14:2819-2830.
35. Sinal C.J., Tohkin M., Miyata M., et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
36. Wang J., Einarsson C., Murphy C., et al. Studies on LXR-and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice. J Lipid Res 2006, 47:421-430.